PCSK9-IN-11
|
P659182-10mg
|
≥99% |
N/A |
10mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
PCSK9-IN-11
|
P659182-100mg
|
≥99% |
N/A |
100mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
Pitavastatin-d5sodium
|
P659177-1mg
|
|
N/A |
1mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
PKCiota-IN-2 formic
|
P659151-5mg
|
≥99% |
N/A |
5mg
|
¥ 4750.9
|
期货,请咨询 |
阿拉丁 |
PKCiota-IN-2 formic
|
P659151-10mg
|
≥99% |
N/A |
10mg
|
¥ 7600.9
|
期货,请咨询 |
阿拉丁 |
PI3K/AKT-IN-1
|
P659144-5mg
|
≥99% |
N/A |
5mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
PI3K/AKT-IN-1
|
P659144-50mg
|
≥99% |
N/A |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
PI3K/AKT-IN-1
|
P659144-25mg
|
≥99% |
N/A |
25mg
|
¥ 9200.9
|
期货,请咨询 |
阿拉丁 |
PI3K/AKT-IN-1
|
P659144-10mg
|
≥99% |
N/A |
10mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
Poly (I:C):Kanamycin (1:1)
|
P659139-50mg
|
|
N/A |
50mg
|
¥ 3600.9
|
期货,请咨询 |
阿拉丁 |
Poly (I:C):Kanamycin (1:1)
|
P659139-25mg
|
|
N/A |
25mg
|
¥ 2100.9
|
期货,请咨询 |
阿拉丁 |
Poly (I:C):Kanamycin (1:1)
|
P659139-10mg
|
|
N/A |
10mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
Poly (I:C):Kanamycin (1:1)
|
P659139-100mg
|
|
N/A |
100mg
|
¥ 5700.9
|
期货,请咨询 |
阿拉丁 |
PARP10/15-IN-1
|
P659130-5mg
|
≥95% |
N/A |
5mg
|
¥ 1800.9
|
期货,请咨询 |
阿拉丁 |
PARP10/15-IN-1
|
P659130-50mg
|
≥95% |
N/A |
50mg
|
¥ 9900.9
|
期货,请咨询 |
阿拉丁 |
PARP10/15-IN-1
|
P659130-25mg
|
≥95% |
N/A |
25mg
|
¥ 6300.9
|
期货,请咨询 |
阿拉丁 |
PARP10/15-IN-1
|
P659130-10mg
|
≥95% |
N/A |
10mg
|
¥ 3150.9
|
期货,请咨询 |
阿拉丁 |
PARP10/15-IN-1
|
P659130-100mg
|
≥95% |
N/A |
100mg
|
¥ 14850.9
|
期货,请咨询 |
阿拉丁 |
PEG2000-DSPE
|
P659113-5mg
|
≥98% |
N/A |
5mg
|
¥ 500.9
|
期货,请咨询 |
阿拉丁 |
PEG2000-DSPE
|
P659113-50mg
|
≥98% |
N/A |
50mg
|
¥ 2600.9
|
期货,请咨询 |
阿拉丁 |
PEG2000-DSPE
|
P659113-25mg
|
≥98% |
N/A |
25mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
PEG2000-DSPE
|
P659113-10mg
|
≥98% |
N/A |
10mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
PEG2000-DSPE
|
P659113-100mg
|
≥98% |
N/A |
100mg
|
¥ 4100.9
|
期货,请咨询 |
阿拉丁 |
PD-1/PD-L1-IN 3 TFA
|
P659098-5mg
|
≥99% |
N/A |
5mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |